CALCITONIN TREATMENT IN LUMBAR SPINAL STENOSIS - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSS-OVER STUDY WITH ONE-YEAR FOLLOW-UP

被引：44

作者：

ESKOLA, A ^{[1
]}

POHJOLAINEN, T ^{[1
]}

ALARANTA, H ^{[1
]}

SOINI, J ^{[1
]}

TALLROTH, K ^{[1
]}

SLATIS, P ^{[1
]}

机构：

[1] ORTHOPED HSO INVALID FDN,HELSINKI,FINLAND

来源：

CALCIFIED TISSUE INTERNATIONAL | 1992年 / 50卷 / 05期

关键词：

CALCITONIN THERAPY; LUMBAR SPINAL STENOSIS;

D O I：

10.1007/BF00296769

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

A randomized, placebo-controlled, double-blind, crossover study in 40 lumbar spinal stenosis patients with a 1-year follow-up showed that calcitonin had beneficial effects on the patients' symptoms without producing any no-table side effects. Calcitonin had a clear analgesic effect. The mean of walking distance increased, but the crossover trend was not as good as the analgesic effect. Side effects such as erythema and nausea were usually mild and transient. Calcitonin therapy can be used as a conservative treatment in selected cases of lumbar spinal stenosis. When rest pain was mild or the walking distance was under 200-300 m because of neurogenic claudication, the effect of calcitonim seemed to be poor.

引用

页码：400 / 403

页数：4

共 13 条

[1]

BERGQUISTULLMAN M, 1977, ACTA ORTHOP SCAND S, V170

[2]

Borg G., 1972, MED SCI SPORTS, V5, P90

[3] CALCITONIN TREATMENT IN LUMBAR SPINAL STENOSIS - CLINICAL OBSERVATIONS - COMMENT [J].